How do you use objective frailty or sarcopenia measures to trigger transplant referral in patients with low MELD?

Frailty and sarcopenia in patients with end-stage liver disease increase pretransplant waitlist mortality and risks of extended stay and complications post-transplant. We all know that a low MELD may be influenced by several factors, and by including creatinine in its formula, sarcopenia may spuriou...